Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Duck Virus Enteritis Vaccine Market Growth 2022-2028

  • LP 4871312
  • 98 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Duck Virus Enteritis Vaccine will have significant change from previous year. According to our (LP Information) latest study, the global Duck Virus Enteritis Vaccine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Duck Virus Enteritis Vaccine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Duck Virus Enteritis Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Duck Virus Enteritis Vaccine market, reaching US$ million by the year 2028. As for the Europe Duck Virus Enteritis Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Duck Virus Enteritis Vaccine players cover Ceva Santé Animale, Chengdu TECBOND Biological, Institute of Animal Health and Veterinary Biologicals, and Institute of Veterinary Preventive Medicine, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Duck Virus Enteritis Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Live Vaccines

Killed Vaccines

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Duck

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Ceva Santé Animale

Chengdu TECBOND Biological

Institute of Animal Health and Veterinary Biologicals

Institute of Veterinary Preventive Medicine

International Duck Research Cooperative

MSD Animal Health (Merck)

Ringpu (Tianjin)Bio-Pharmacy

Veterinary Research Institute

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Duck Virus Enteritis Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Duck Virus Enteritis Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Duck Virus Enteritis Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Duck Virus Enteritis Vaccine Segment by Type

2.2.1 Live Vaccines

2.2.2 Killed Vaccines

2.3 Duck Virus Enteritis Vaccine Sales by Type

2.3.1 Global Duck Virus Enteritis Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Duck Virus Enteritis Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Duck Virus Enteritis Vaccine Sale Price by Type (2017-2022)

2.4 Duck Virus Enteritis Vaccine Segment by Application

2.4.1 Duck

2.4.2 Others

2.5 Duck Virus Enteritis Vaccine Sales by Application

2.5.1 Global Duck Virus Enteritis Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Duck Virus Enteritis Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Duck Virus Enteritis Vaccine Sale Price by Application (2017-2022)

3 Global Duck Virus Enteritis Vaccine by Company

3.1 Global Duck Virus Enteritis Vaccine Breakdown Data by Company

3.1.1 Global Duck Virus Enteritis Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Duck Virus Enteritis Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Duck Virus Enteritis Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Duck Virus Enteritis Vaccine Revenue by Company (2020-2022)

3.2.2 Global Duck Virus Enteritis Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Duck Virus Enteritis Vaccine Sale Price by Company

3.4 Key Manufacturers Duck Virus Enteritis Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Duck Virus Enteritis Vaccine Product Location Distribution

3.4.2 Players Duck Virus Enteritis Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Duck Virus Enteritis Vaccine by Geographic Region

4.1 World Historic Duck Virus Enteritis Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Duck Virus Enteritis Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Duck Virus Enteritis Vaccine Annual Revenue by Geographic Region

4.2 World Historic Duck Virus Enteritis Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Duck Virus Enteritis Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Duck Virus Enteritis Vaccine Annual Revenue by Country/Region

4.3 Americas Duck Virus Enteritis Vaccine Sales Growth

4.4 APAC Duck Virus Enteritis Vaccine Sales Growth

4.5 Europe Duck Virus Enteritis Vaccine Sales Growth

4.6 Middle East & Africa Duck Virus Enteritis Vaccine Sales Growth

5 Americas

5.1 Americas Duck Virus Enteritis Vaccine Sales by Country

5.1.1 Americas Duck Virus Enteritis Vaccine Sales by Country (2017-2022)

5.1.2 Americas Duck Virus Enteritis Vaccine Revenue by Country (2017-2022)

5.2 Americas Duck Virus Enteritis Vaccine Sales by Type

5.3 Americas Duck Virus Enteritis Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Duck Virus Enteritis Vaccine Sales by Region

6.1.1 APAC Duck Virus Enteritis Vaccine Sales by Region (2017-2022)

6.1.2 APAC Duck Virus Enteritis Vaccine Revenue by Region (2017-2022)

6.2 APAC Duck Virus Enteritis Vaccine Sales by Type

6.3 APAC Duck Virus Enteritis Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Duck Virus Enteritis Vaccine by Country

7.1.1 Europe Duck Virus Enteritis Vaccine Sales by Country (2017-2022)

7.1.2 Europe Duck Virus Enteritis Vaccine Revenue by Country (2017-2022)

7.2 Europe Duck Virus Enteritis Vaccine Sales by Type

7.3 Europe Duck Virus Enteritis Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Duck Virus Enteritis Vaccine by Country

8.1.1 Middle East & Africa Duck Virus Enteritis Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Duck Virus Enteritis Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Duck Virus Enteritis Vaccine Sales by Type

8.3 Middle East & Africa Duck Virus Enteritis Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Duck Virus Enteritis Vaccine

10.3 Manufacturing Process Analysis of Duck Virus Enteritis Vaccine

10.4 Industry Chain Structure of Duck Virus Enteritis Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Duck Virus Enteritis Vaccine Distributors

11.3 Duck Virus Enteritis Vaccine Customer

12 World Forecast Review for Duck Virus Enteritis Vaccine by Geographic Region

12.1 Global Duck Virus Enteritis Vaccine Market Size Forecast by Region

12.1.1 Global Duck Virus Enteritis Vaccine Forecast by Region (2023-2028)

12.1.2 Global Duck Virus Enteritis Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Duck Virus Enteritis Vaccine Forecast by Type

12.7 Global Duck Virus Enteritis Vaccine Forecast by Application

13 Key Players Analysis

13.1 Ceva Santé Animale

13.1.1 Ceva Santé Animale Company Information

13.1.2 Ceva Santé Animale Duck Virus Enteritis Vaccine Product Offered

13.1.3 Ceva Santé Animale Duck Virus Enteritis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Ceva Santé Animale Main Business Overview

13.1.5 Ceva Santé Animale Latest Developments

13.2 Chengdu TECBOND Biological

13.2.1 Chengdu TECBOND Biological Company Information

13.2.2 Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Product Offered

13.2.3 Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Chengdu TECBOND Biological Main Business Overview

13.2.5 Chengdu TECBOND Biological Latest Developments

13.3 Institute of Animal Health and Veterinary Biologicals

13.3.1 Institute of Animal Health and Veterinary Biologicals Company Information

13.3.2 Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Product Offered

13.3.3 Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Institute of Animal Health and Veterinary Biologicals Main Business Overview

13.3.5 Institute of Animal Health and Veterinary Biologicals Latest Developments

13.4 Institute of Veterinary Preventive Medicine

13.4.1 Institute of Veterinary Preventive Medicine Company Information

13.4.2 Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Product Offered

13.4.3 Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Institute of Veterinary Preventive Medicine Main Business Overview

13.4.5 Institute of Veterinary Preventive Medicine Latest Developments

13.5 International Duck Research Cooperative

13.5.1 International Duck Research Cooperative Company Information

13.5.2 International Duck Research Cooperative Duck Virus Enteritis Vaccine Product Offered

13.5.3 International Duck Research Cooperative Duck Virus Enteritis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 International Duck Research Cooperative Main Business Overview

13.5.5 International Duck Research Cooperative Latest Developments

13.6 MSD Animal Health (Merck)

13.6.1 MSD Animal Health (Merck) Company Information

13.6.2 MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Product Offered

13.6.3 MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 MSD Animal Health (Merck) Main Business Overview

13.6.5 MSD Animal Health (Merck) Latest Developments

13.7 Ringpu (Tianjin)Bio-Pharmacy

13.7.1 Ringpu (Tianjin)Bio-Pharmacy Company Information

13.7.2 Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Product Offered

13.7.3 Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Ringpu (Tianjin)Bio-Pharmacy Main Business Overview

13.7.5 Ringpu (Tianjin)Bio-Pharmacy Latest Developments

13.8 Veterinary Research Institute

13.8.1 Veterinary Research Institute Company Information

13.8.2 Veterinary Research Institute Duck Virus Enteritis Vaccine Product Offered

13.8.3 Veterinary Research Institute Duck Virus Enteritis Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Veterinary Research Institute Main Business Overview

13.8.5 Veterinary Research Institute Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Duck Virus Enteritis Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Duck Virus Enteritis Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Live Vaccines

Table 4. Major Players of Killed Vaccines

Table 5. Global Duck Virus Enteritis Vaccine Sales by Type (2017-2022) & (K Units)

Table 6. Global Duck Virus Enteritis Vaccine Sales Market Share by Type (2017-2022)

Table 7. Global Duck Virus Enteritis Vaccine Revenue by Type (2017-2022) & ($ million)

Table 8. Global Duck Virus Enteritis Vaccine Revenue Market Share by Type (2017-2022)

Table 9. Global Duck Virus Enteritis Vaccine Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Duck Virus Enteritis Vaccine Sales by Application (2017-2022) & (K Units)

Table 11. Global Duck Virus Enteritis Vaccine Sales Market Share by Application (2017-2022)

Table 12. Global Duck Virus Enteritis Vaccine Revenue by Application (2017-2022)

Table 13. Global Duck Virus Enteritis Vaccine Revenue Market Share by Application (2017-2022)

Table 14. Global Duck Virus Enteritis Vaccine Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Duck Virus Enteritis Vaccine Sales by Company (2020-2022) & (K Units)

Table 16. Global Duck Virus Enteritis Vaccine Sales Market Share by Company (2020-2022)

Table 17. Global Duck Virus Enteritis Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Duck Virus Enteritis Vaccine Revenue Market Share by Company (2020-2022)

Table 19. Global Duck Virus Enteritis Vaccine Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Duck Virus Enteritis Vaccine Producing Area Distribution and Sales Area

Table 21. Players Duck Virus Enteritis Vaccine Products Offered

Table 22. Duck Virus Enteritis Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Duck Virus Enteritis Vaccine Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Duck Virus Enteritis Vaccine Sales Market Share Geographic Region (2017-2022)

Table 27. Global Duck Virus Enteritis Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Duck Virus Enteritis Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Duck Virus Enteritis Vaccine Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Duck Virus Enteritis Vaccine Sales Market Share by Country/Region (2017-2022)

Table 31. Global Duck Virus Enteritis Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Duck Virus Enteritis Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Duck Virus Enteritis Vaccine Sales by Country (2017-2022) & (K Units)

Table 34. Americas Duck Virus Enteritis Vaccine Sales Market Share by Country (2017-2022)

Table 35. Americas Duck Virus Enteritis Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Duck Virus Enteritis Vaccine Revenue Market Share by Country (2017-2022)

Table 37. Americas Duck Virus Enteritis Vaccine Sales by Type (2017-2022) & (K Units)

Table 38. Americas Duck Virus Enteritis Vaccine Sales Market Share by Type (2017-2022)

Table 39. Americas Duck Virus Enteritis Vaccine Sales by Application (2017-2022) & (K Units)

Table 40. Americas Duck Virus Enteritis Vaccine Sales Market Share by Application (2017-2022)

Table 41. APAC Duck Virus Enteritis Vaccine Sales by Region (2017-2022) & (K Units)

Table 42. APAC Duck Virus Enteritis Vaccine Sales Market Share by Region (2017-2022)

Table 43. APAC Duck Virus Enteritis Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Duck Virus Enteritis Vaccine Revenue Market Share by Region (2017-2022)

Table 45. APAC Duck Virus Enteritis Vaccine Sales by Type (2017-2022) & (K Units)

Table 46. APAC Duck Virus Enteritis Vaccine Sales Market Share by Type (2017-2022)

Table 47. APAC Duck Virus Enteritis Vaccine Sales by Application (2017-2022) & (K Units)

Table 48. APAC Duck Virus Enteritis Vaccine Sales Market Share by Application (2017-2022)

Table 49. Europe Duck Virus Enteritis Vaccine Sales by Country (2017-2022) & (K Units)

Table 50. Europe Duck Virus Enteritis Vaccine Sales Market Share by Country (2017-2022)

Table 51. Europe Duck Virus Enteritis Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Duck Virus Enteritis Vaccine Revenue Market Share by Country (2017-2022)

Table 53. Europe Duck Virus Enteritis Vaccine Sales by Type (2017-2022) & (K Units)

Table 54. Europe Duck Virus Enteritis Vaccine Sales Market Share by Type (2017-2022)

Table 55. Europe Duck Virus Enteritis Vaccine Sales by Application (2017-2022) & (K Units)

Table 56. Europe Duck Virus Enteritis Vaccine Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Duck Virus Enteritis Vaccine Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Duck Virus Enteritis Vaccine Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Duck Virus Enteritis Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Duck Virus Enteritis Vaccine Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Duck Virus Enteritis Vaccine Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Duck Virus Enteritis Vaccine Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Duck Virus Enteritis Vaccine Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Duck Virus Enteritis Vaccine Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Duck Virus Enteritis Vaccine

Table 66. Key Market Challenges & Risks of Duck Virus Enteritis Vaccine

Table 67. Key Industry Trends of Duck Virus Enteritis Vaccine

Table 68. Duck Virus Enteritis Vaccine Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Duck Virus Enteritis Vaccine Distributors List

Table 71. Duck Virus Enteritis Vaccine Customer List

Table 72. Global Duck Virus Enteritis Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Duck Virus Enteritis Vaccine Sales Market Forecast by Region

Table 74. Global Duck Virus Enteritis Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Duck Virus Enteritis Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Duck Virus Enteritis Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Duck Virus Enteritis Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Duck Virus Enteritis Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Duck Virus Enteritis Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Duck Virus Enteritis Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Duck Virus Enteritis Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Duck Virus Enteritis Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Duck Virus Enteritis Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Duck Virus Enteritis Vaccine Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Duck Virus Enteritis Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Duck Virus Enteritis Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Duck Virus Enteritis Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Duck Virus Enteritis Vaccine Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Duck Virus Enteritis Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Duck Virus Enteritis Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Duck Virus Enteritis Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 92. Ceva Santé Animale Basic Information, Duck Virus Enteritis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 93. Ceva Santé Animale Duck Virus Enteritis Vaccine Product Offered

Table 94. Ceva Santé Animale Duck Virus Enteritis Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. Ceva Santé Animale Main Business

Table 96. Ceva Santé Animale Latest Developments

Table 97. Chengdu TECBOND Biological Basic Information, Duck Virus Enteritis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 98. Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Product Offered

Table 99. Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Chengdu TECBOND Biological Main Business

Table 101. Chengdu TECBOND Biological Latest Developments

Table 102. Institute of Animal Health and Veterinary Biologicals Basic Information, Duck Virus Enteritis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 103. Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Product Offered

Table 104. Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Institute of Animal Health and Veterinary Biologicals Main Business

Table 106. Institute of Animal Health and Veterinary Biologicals Latest Developments

Table 107. Institute of Veterinary Preventive Medicine Basic Information, Duck Virus Enteritis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 108. Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Product Offered

Table 109. Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Institute of Veterinary Preventive Medicine Main Business

Table 111. Institute of Veterinary Preventive Medicine Latest Developments

Table 112. International Duck Research Cooperative Basic Information, Duck Virus Enteritis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 113. International Duck Research Cooperative Duck Virus Enteritis Vaccine Product Offered

Table 114. International Duck Research Cooperative Duck Virus Enteritis Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. International Duck Research Cooperative Main Business

Table 116. International Duck Research Cooperative Latest Developments

Table 117. MSD Animal Health (Merck) Basic Information, Duck Virus Enteritis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 118. MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Product Offered

Table 119. MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. MSD Animal Health (Merck) Main Business

Table 121. MSD Animal Health (Merck) Latest Developments

Table 122. Ringpu (Tianjin)Bio-Pharmacy Basic Information, Duck Virus Enteritis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 123. Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Product Offered

Table 124. Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 125. Ringpu (Tianjin)Bio-Pharmacy Main Business

Table 126. Ringpu (Tianjin)Bio-Pharmacy Latest Developments

Table 127. Veterinary Research Institute Basic Information, Duck Virus Enteritis Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 128. Veterinary Research Institute Duck Virus Enteritis Vaccine Product Offered

Table 129. Veterinary Research Institute Duck Virus Enteritis Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 130. Veterinary Research Institute Main Business

Table 131. Veterinary Research Institute Latest Developments

List of Figures

Figure 1. Picture of Duck Virus Enteritis Vaccine

Figure 2. Duck Virus Enteritis Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Duck Virus Enteritis Vaccine Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Duck Virus Enteritis Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Duck Virus Enteritis Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Live Vaccines

Figure 10. Product Picture of Killed Vaccines

Figure 11. Global Duck Virus Enteritis Vaccine Sales Market Share by Type in 2021

Figure 12. Global Duck Virus Enteritis Vaccine Revenue Market Share by Type (2017-2022)

Figure 13. Duck Virus Enteritis Vaccine Consumed in Duck

Figure 14. Global Duck Virus Enteritis Vaccine Market: Duck (2017-2022) & (K Units)

Figure 15. Duck Virus Enteritis Vaccine Consumed in Others

Figure 16. Global Duck Virus Enteritis Vaccine Market: Others (2017-2022) & (K Units)

Figure 17. Global Duck Virus Enteritis Vaccine Sales Market Share by Application (2017-2022)

Figure 18. Global Duck Virus Enteritis Vaccine Revenue Market Share by Application in 2021

Figure 19. Duck Virus Enteritis Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Duck Virus Enteritis Vaccine Revenue Market Share by Company in 2021

Figure 21. Global Duck Virus Enteritis Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Duck Virus Enteritis Vaccine Revenue Market Share by Geographic Region in 2021

Figure 23. Global Duck Virus Enteritis Vaccine Sales Market Share by Region (2017-2022)

Figure 24. Global Duck Virus Enteritis Vaccine Revenue Market Share by Country/Region in 2021

Figure 25. Americas Duck Virus Enteritis Vaccine Sales 2017-2022 (K Units)

Figure 26. Americas Duck Virus Enteritis Vaccine Revenue 2017-2022 ($ Millions)

Figure 27. APAC Duck Virus Enteritis Vaccine Sales 2017-2022 (K Units)

Figure 28. APAC Duck Virus Enteritis Vaccine Revenue 2017-2022 ($ Millions)

Figure 29. Europe Duck Virus Enteritis Vaccine Sales 2017-2022 (K Units)

Figure 30. Europe Duck Virus Enteritis Vaccine Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Duck Virus Enteritis Vaccine Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Duck Virus Enteritis Vaccine Revenue 2017-2022 ($ Millions)

Figure 33. Americas Duck Virus Enteritis Vaccine Sales Market Share by Country in 2021

Figure 34. Americas Duck Virus Enteritis Vaccine Revenue Market Share by Country in 2021

Figure 35. United States Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Duck Virus Enteritis Vaccine Sales Market Share by Region in 2021

Figure 40. APAC Duck Virus Enteritis Vaccine Revenue Market Share by Regions in 2021

Figure 41. China Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Duck Virus Enteritis Vaccine Sales Market Share by Country in 2021

Figure 48. Europe Duck Virus Enteritis Vaccine Revenue Market Share by Country in 2021

Figure 49. Germany Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Duck Virus Enteritis Vaccine Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Duck Virus Enteritis Vaccine Revenue Market Share by Country in 2021

Figure 56. Egypt Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Duck Virus Enteritis Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Duck Virus Enteritis Vaccine in 2021

Figure 62. Manufacturing Process Analysis of Duck Virus Enteritis Vaccine

Figure 63. Industry Chain Structure of Duck Virus Enteritis Vaccine

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390